U.S. Markets for Specialty Endoscopic Surgery Products, July 2014

Over the past several decades, a revolutionary transition has occurred among many surgical procedures that has taken them from an invasive open approach to minimally invasive/endoscopic methods due to advances in medical technology and surgical techniques.  The adoption of endoscopy for many procedures has greatly benefited patients, as it reduces pain, recovery time, and scarring as well as hospital costs.  The emergence of small-incision and incisionless procedures has resulted in the availability of a wide selection of next-generation endoscopes, hand instruments, trocars, and other related devices and instruments.  As the use of endoscopy continues to expand, a wide range of specialty procedures has emerged, particularly in the fields of arthroscopy, ENT, neurology, and thoracic surgery.  

This dynamic, new report from Medtech Insight includes analyses of products, current/forecast markets, surgical procedure volumes, competitors, and opportunities in the U.S. Specialty Endoscopic Surgery Products Market.  (Note: general/laparoscopic/pelvic/gynecologic, and urologic endoscopic procedures and related products are primarily discussed in Medtech Insight companion Report #A530, U.S. Markets for General and Pelvic Surgical Products.)  

The 4 core product areas covered by the scope of this report include:  endoscopes, hand instruments, suction/irrigation/fluid management products, and trocars used in specialty endoscopy.

During the forecast period covered by this report, the combined U.S. market for specialty endoscopic surgery products (as defined in this report) is projected to increase from approximately $2.9 billion in 2013 to more than $4.0 billion in the year 2018.  Compound annual growth in individual endoscopic device segments is expected to range from approximately 5.6% (for specialty trocars), 5.8% (specialty endoscopes), 7.2% (specialty hand instruments), and 7.6% (suction/irrigation systems), over the forecast period.